The BCR binds antigen for processing and subsequent presentation on MHC II molecules. Polyvalent antigen induces BCR clustering and targeting to endocytic processing compartments, which are also accessed by Ii-MHC II. Here, we report that clustered BCR is able to team up with Ii-MHC II already at the plasma membrane of mouse B-lymphocytes. Colocalization of BCR and Ii-MHC II on the cell surface required clustering of both types of molecules. The clustering of only one type did not trigger the recruitment of the other. Ii-bound MIF (a ligand of Ii) also colocalized with clustered BCR upon oligomerization of MIF on the surface of the B cell. Abundant surface molecules, such as B220 or TfnR, did not cocluster with the BCR. Some membrane raft-associated molecules, such as peptide-loaded MHC II, coclustered with the BCR, whereas others, such as G M 1, did not. The formation of a BCR-and Ii-MHC II-containing membrane domain by antibody-mediated clustering was independent of F-actin and led to the coendocytosis of its constituents. With a rapid Brij 98 extraction method, it was possible to capture this membrane domain biochemically as a DRM. Ii and clustered BCR were present on the same DRM, as shown by immunoisolation. The coalescence of BCR and Ii-MHC II increased tyrosine phosphorylation, indicative of enhanced BCR signaling. Our work suggests a novel role for MIF and Ii-MHC II in BCR-mediated antigen processing. J. Leukoc. Biol. 96: 843-855; 2014.
Introduction
B-Lymphocytes play an essential role in antibody-mediated adaptive immune reactions. The binding of the antigen to the BCR triggers MHC-II-dependent presentation of antigen-derived peptides to specific CD4 ϩ T cells. These provide signals for B cell proliferation and differentiation [1] . The BCR is composed of a membrane-anchored Ig, mediating antigen detection and binding, and an Ig␣-Ig␤ heterodimer that is associated with the antigen-binding module in a 1:1 stoichiometry [2, 3] . The receptor is responsible for two key events in B cell activation: the internalization of antigen and the triggering of a downstream signaling cascade involving protein tyrosine phosphorylation, phospholipase C/protein kinase C activation [4, 5] . The outcome of antigen-BCR interaction depends on the capacity of the antigen to cluster the BCR: whereas a monomeric, soluble antigen triggered initial signaling and only a low level of antigen presentation, a polyvalent or membraneassociated monomeric antigen induced strong responses [6 -9] . It has been proposed that this effect is a result of the transient recruitment of clustered BCR to membrane rafts [7, 10] . These are short-lived, nanometer-sized regions of biological membranes enriched in cholesterol, sphingolipids, and subsets of membrane proteins [11, 12] . They can be stabilized to form larger platforms through protein-protein and protein-lipid interactions and exert functions in signal transduction and molecular sorting [12] . BCR has been shown to be present in TX-100-resistant membranes (TX-100 DRMs) [13] [14] [15] [16] [17] , a property serving as a surrogate criterion for membrane raft association. However, in most cases, DRM association of BCR was low, only induced after clustering and in some instances, only preserved at a very low detergent concentration [14] or in detergents normally used to dissolve cholesterol and sphingolipid-rich DRMs [8] . Taken together, these observations suggest a regulated association of the BCR with an unusual type of membrane raft. In support of this view, direct evidence for the formation of a raft-like microenvironment upon BCR clustering and its role in signal transduction has been provided in a model system of an immunological synapse [3] . Whereas membrane rafts appear to be involved in BCR-driven signal transduction, their role in the internalization of the BCR is less clear: membrane rafts have been implicated in clathrin-dependent and -independent internalization of clustered BCR in some systems [18, 19] but not in others [15] .
After internalization, clustered BCR is thought to deliver antigen to late endocytic compartments, where it meets newly synthesized MHC II bound to Ii [20] . There, Ii, BCR, and antigen are degraded, and antigen-derived peptides associate with the released MHC II. Multiple links between BCR signaling and BCR internalization [21] [22] [23] [24] and between BCR signaling and the accumulation of Ii-MHC II complexes at degradative endocytic compartments have been reported [8, 25, 26] . Work of the Lennon-Dumenil laboratory [27] revealed that polyvalent BCR engagement induced phosphorylation of myosin II light chain, causing myosin II to interact with Ii. This led to the convergence of BCR-antigen complexes and Ii-MHC II at lamp-1-positive compartments and to the presentation of processed antigen.
It remains to be established, however, where the pathways of Ii-MHC II and antigen-loaded BCR intersect. Newly synthesized Ii-MHC II complexes are targeted to the plasma membrane and early endosomes, although the precise itinerary is still debated [28 -30] . In principle, Ii-MHC II complexes could meet clustered BCR as early as at the plasma membrane. Ii-MHC II complexes are resistant to detergent extraction at the plasma membrane and in endosomes, suggesting that they are present in a raft-like membrane environment [31, 32] . As membrane rafts are heterogeneous [33, 34] , a potential association between BCR and Ii-MHC II might be driven by a preference for the same membrane environment. We therefore investigated whether Ii-MHC II was capable of associating with clustered BCR at the cell surface and whether membrane rafts played a role in this process.
MATERIALS AND METHODS

Reagents
Antibodies against B220 (RA3-6B2; rat), TfnR (C2; rat), and lamp-1 (1D4B; rat) were obtained from BD Biosciences (Heidelberg, Germany). Polyclonal anti-MIF (rabbit) was bought from Invitrogen (Darmstadt, Germany). Other mAb {10.2.16 (anti-MHC II; mouse) [31] ; P7/7 (anti-MHC IIb; rat) [35] ; H116-32 (anti-MHC IIa; mouse) [36] ; P4H5 (anti-Ii; hamster) [37] ; In-1 (anti-Ii; rat) [31] ; and MAR18.5 (anti-rat Ig; mouse) [31] } were used as cell culture supernatants. The polyclonal anti-MHC II ␣-chain antibody has been described earlier [38] ; the antiserum against the mouse MHC II (A k ) ␤-chain sequence 252 GPRGPPPAGLLQ 263 was produced accordingly. mAb 4G10 (anti-phosphotyrosine; mouse) was kindly supplied by Dr. Teruko. Tamura-Niemann (Hannover Medical School, Germany). The Fc␥R-blocking mAb 2.4G2 (rat) was a gift of Dr. Engelbert Gessner (Hannover Medical School). Anti-phospho-Akt (mAb D9E; Cell Signaling Technology, Leiden, The Netherlands), anti-pan-Akt (mAb C67E7; Cell Signaling Technology), anti-phospho-Erk1/2 (mAb E10; Cell Signaling Technology), and anti-Erk2 (C-14; Santa Cruz Biotechnology, Heidelberg, Germany) antibodies were kindly provided by Drs. Peter Claus and Matthias Gaestel (both Hannover Medical School), respectively. Antibodies to phospho-Lyn (polyclonal) and Lyn (LYN-01) were obtained from Cell Signaling Technology and Exbio (Vestec, Czech Republic), respectively. BCR was detected with fluorophore-conjugated F(ab=) 2 goat anti-mouse IgM (HCϩLC; Dianova, Hamburg, Germany), fluorophore-conjugated goat anti-mouse IgG (HCϩLC; Invitrogen), or goat anti-mouse IgM (adsorbed against mouse IgG; SouthernBiotech, Eching, Germany). All polyclonal reagents were highly cross-adsorbed and were when appropriate, additionally adsorbed against mAb P4H5 (hamster). ProLong mounting medium was obtained from Invitrogen. Purified CTB and anti-CTB were from Quadratech Diagnostics (Surrey, UK). FITC-labeled CTB, Brij 98, LPS, poly-L-lysine, and the S-value standards Myo, Ova, albumin, AP, aldolase, and catalase were bought from Sigma (Taufkirchen, Germany). Neutravidin-HRP, NHSS-SSbiotin, and the BCA protein assay were from Thermo Scientific (Bonn, Germany). S4B, PGS, CNBr-activated S4B, and ECL films were obtained from GE-Healthcare (Braunschweig, Germany). Sucrose and DNase I were obtained from Calbiochem (Schwalbach, Germany). Nitrocellulose (BA83) was bought from Merck Millipore (Schwalbach, Germany). All other chemicals were of analytical grade and were obtained from Sigma or Merck/VWR (Darmstadt, Germany).
Cells
The mouse B cell lines M12.C3 [39] , M12.C3.F6 [40] , and CH27 [40] have been described. NHHT-39 was obtained by stable transfection of M12.C3.F6 with cDNA encoding membrane-anchored IgM and was a kind gift of Drs. Christopher Nelson and Emil Unanue (Washington University Medical School, St. Louis, MO, USA). Primary B cells were isolated from spleens of male C3H mice, as described earlier [28] , and expanded for 48 h in medium, supplemented with 10 g/ml LPS. All cell lines were cultured as published [40] .
Immunoadsorption of antibodies against hamster Ig
mAb P4H5 was purified from culture supernatants on PGS following the manufacturer's protocol. Purified mAb P4H5 was coupled to CNBr-activated S4B, as described by the manufacturer. This matrix was used to adsorb anti-hamster IgG reactivity from fluorophore-conjugated polyclonal antibodies. For this purpose, 80 l antibody (as supplied) was slowly rotated with 25 l matrix in a total volume of 400 l PBS, 1% BSA, and 0.02% NaN 3 for 8 -12 h at 4°C. After removal of the beads, the absence of cross-reactivity to hamster IgG was checked by FACS.
Antibody-mediated clustering
Immunofluorescent-coclustering assays were performed, as described [40] . Briefly, NHHT-39 cells (1ϫ10 6 ) were incubated with 10 g/ml primary antibody in WB (1% BSA in HBSS) for 1 h on ice, washed, and incubated with highly cross-adsorbed secondary antibodies (5 g/ml in WB; 1 g/ml in the case of FITC-CTB) for 1 h on ice. After washing, cells were resuspended in 100 l WB and warmed to 37°C for 5 min for clustering or 10 -15 min for subsequent endocytosis. Cells were fixed with 4% PFA in PBS and quenched with 50 mM NH 4 Cl in WB. After transfer onto polylysine-coated coverslips, cells were mounted and inspected on a Zeiss 510 CLSM. Z-Stacks were recorded with optical sections of 0.6 m thickness. Controls were stained with mismatched primary and secondary antibodies and did not give a detectable signal at our photomultiplier settings. For experiments with mAb P4H5 (hamster), only P4H5-adsorbed anti-BCR antibodies were used. For MIF coclustering experiments, NHHT-39 cells were incubated with 1 g/ml MIF in WB for 1 h on ice before the antibody incubations. Analysis of coclustering was done on tangential confocal sections using ImageJ (NIH, Bethesda, MD, USA), JaCoP [41] , and Prism (GraphPad Software, La Jolla, CA, USA).
For clustering experiments involving subsequent detergent extraction, NHHT-39 cells (3ϫ10 7 -1ϫ10 8 ) were treated with antibodies against BCR [anti-mouse IgM F(ab=) 2 , adsorbed against mAb P4H5] in the absence or presence of mAb P4H5 for 1 h on ice. mAb P4H5 was then reacted with cross-adsorbed goat anti-hamster antibodies for 1 h on ice. Incubations were performed at an antibody concentration of 15 g/ml in WB. After washing, cells were resuspended in 1 ml WB and warmed up to 37°C for 5 min to allow for patch formation.
Interference with actin polymerization
To inhibit actin polymerization, 1 M Lat B was present throughout all incubations of the coclustering protocol (see above). To prove the efficacy of Lat B treatment, cells were mock-incubated in the presence or absence of Lat B. After fixation with 4% PFA in PBS and permeabilization with 0.05% saponin in WB, the cells were incubated with FITC-phalloidin (40 nM) in WB containing 0.05% saponin for 1.5 h at RT. Further analysis was by CLSM with unstained cells as negative controls.
Preparation of PNMs
For the long Brij 98 extraction procedure, PNMs were prepared as described [31] . For the short Brij 98 procedure, PNMs were prepared, according to a modified published protocol [42] . Briefly, NHHT-39 cells (5ϫ10 7 ) were suspended in 1.6 ml triethanolamine homogenization buffer (10 mM triethanolamine, 10 mM acetic acid, 1 mM EDTA, 250 mM sucrose, 0.02% NaN 3 , pHϭ7.4); supplemented with protease inhibitors (5.1 g/ml leupeptin, 1 g/ml pepstatin, 1 g/ml E-64, 0.1 mM PMSF, 5 mM iodoacetamide) and phosphatase inhibitors (5 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , 10 mM NaF); and incubated 20 min on ice. Homogenization was done by gentle sonification (10 bursts of 1-s duration using a Branson Sonifier 250 at output control setting 2). After centrifugation (1000 g, 10 min, 4°C), DNase I (100 g/ml) was added and incubated 30 min on ice. PNMs were pelleted by ultracentrifugation (Beckman-Coulter TLA 100.4, 90,000 rpm, 15 min, 4°C; Beckman-Coulter, Krefeld, Germany).
Extraction of DRMs
The TX-100 extraction procedure was performed as described [43] . Briefly, after coclustering, 1 ϫ 10 8 NHHT-39 cells were lysed directly for 30 min on ice in a final volume of 1 ml TNEV ϩ [10 mM Tris, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , and protease inhibitors (see above), pHϭ7.5], supplemented with 1% TX-100. After low-speed centrifugation (1000 g, 10 min, 4°C), the supernatant (ϳ6.67 mg protein in 1 ml) was mixed with 1 ml 85% sucrose in TNEV ϩ , transferred to an SW40 tube, and overlaid with a sucrose step gradient (6 ml 35% sucrose, 3 ml 5% sucrose, all in TNEV ϩ ). After ultracentrifugation (Beckman-Coulter SW-40, 20.5 h, 36,000 rpm, 4°C), 11, 1-ml fractions were retrieved from the top, and the pellet was resuspended in a 1-ml gradient buffer.
The long Brij 98 extraction procedure has been described [40] . Briefly, after coclustering, PNMs were prepared from 3 ϫ 10 7 NHHT-39 cells and extracted in 500 l MB (20 mM MES, pHϭ6.5, 150 mM NaCl, 1% Brij 98) and protease inhibitors (ϭMB ϩ ). Extraction was for 14 -16 h on ice, followed by 5 min at 37°C. The extract (2 mg protein/ml) was mixed with 500 l 90% sucrose in MB, transferred into an SW40 tube, and overlaid with a linear 10 -40% sucrose gradient in MB ϩ . Ultracentrifugation and fractionation were as above.
The short Brij 98 extraction procedure was performed as described [42] with slight modifications: after coclustering and PNM preparation from 5 ϫ 10 7 NHHT-39 cells, the PNM pellet was resuspended in 300 l buffer D (25 mM HEPES, pHϭ7.4, 150 mM NaCl, 1 mM EGTA) supplemented with phosphatase and protease inhibitors (ϭD ϩ ) and warmed to 37°C. Then, 33 l prewarmed 5% Brij 98 was added, followed by 5 min incubation at 37°C. The extract was adjusted with buffer D ϩ to 500 l (3.1 mg protein/ml) and mixed with 500 l 90% sucrose in buffer D on ice. Fiftyfive minutes after the 37°C extraction, the sample was overlaid with a 10 -40% sucrose gradient (in buffer D ϩ ) in an SW40 tube. Ultracentrifugation and fractionation were done as above.
Immunoisolation
The clustering of BCR with anti-IgM F(ab=) 2 
Sedimentation analysis and immunoprecipitation
M12.C3.F6 cells ( 3ϫ10 7 ) were surface-biotinylated with NHSS-SS-biotin [31] and lysed in 500 l TBST (50 mM Tris/HCl, pHϭ7.5, 100 mM NaCl, 1% TX-100, 0.02% NaN 3 ) and protease inhibitors (ϭTBST ϩ ) for 1 h on ice. TBST ϩ lysates were cleared by ultracentrifugation (Beckman-Coulter TLA55, 50,000 rpm, 40 min, 4°C) before layering them onto linear 7.5-15% sucrose gradients (in TBST ϩ ). For calibration purposes, a mixture of proteins with known S-values was dissolved in TBST ϩ and layered on a parallel gradient. Ultracentrifugation was at 36,000 rpm for 36 h at 4°C in an SW40 rotor (Beckman-Coulter). Gradients were fractionated in 23 ϫ 500-l fractions plus pellet from the top. A 400-l aliquot of every gradient fraction was diluted with 400 l TBST ϩ and subjected to immunoprecipitation with the mAb In-1 and MAR 18.5, as described [31] . Sequential immunoprecipitation from cleared TBST ϩ lysates of surface-biotinylated M12.C3.F6 cells ( 8ϫ10 7 ) was first done with mAb In-1 and MAR 18.5 using protein A-sepharose for retrieval of the immune complexes. Bound polypeptides were eluted by boiling in nonreducing SDS sample buffer. Fifteen percent of the eluate was kept for further analysis, and the remaining 85% was diluted 1:20 with TBST, supplemented with 0.1% BSA, protease inhibitors, and 2 mM iodoacetamide (final concentration of SDS: 0.1%). The sample was then split into two aliquots and subjected to a second round of immunoprecipitation using MHC II ␣-or ␤-chain-specific antisera and protein A-sepharose for retrieval. After elution by boiling with nonreducing SDS sample buffer, biotinylated peptides in the primary and the secondary immunoprecipitates were visualized by Western blotting with neutravidin-HRP as described [31] .
Analysis of protein phosphorylation
NHHT-39 cells (2ϫ10 6 ) were treated with anti-mouse IgM F(ab=) 2 (HCϩLC) or anti-IgG (HCϩLC; both P4H5-adsorbed) in the presence or absence of mAb P4H5, as described in the clustering protocol. After labeling, the cells (in 100 l WB) were warmed up to 37°C for 2, 5, 10, 15, or 30 min or left on ice (0 min). Reactions were stopped by addition of 1 ml ice-cold HBSS. The cells were spun down immediately (2400 rpm, 1 min, 2°C), and the pellet was lysed in TBST ϩ buffer, supplemented with phosphatase inhibitors for 30 min on ice. After removal of the nuclei, the samples were boiled in reducing SDS-sample buffer and Western-blotted for (1) phosphorylated tyrosine and TfnR or pan-Akt (loading controls); (2) phospho-Erk1/2 and Erk2 (loading control, after stripping); and (3) phospho-Akt and pan-Akt (loading control, after stripping). The stripping reactions for reprobing the Western blots were done according to the antibody manufacturer's recommendations. To allow for comparison of phosphorylation data obtained in different experiments, we set the sum of all relative phosphorylation values (ϭphosphorylated/nonphosphorylated control) of a given experiment consisting of a control and a BCR-clustered and a BCRand Ii-clustered set of four time-points to 100. Thus, all relative phosphorylation values were calculated as percentages of the sum of the three sets of one experiment.
Protein methods
BCA protein assay, SDS-PAGE, immunoblotting, and densitometric quantification were performed as described [31] . Western blots were developed with a mixture of 4 ml of 0.25 mg/ml luminol in 0.1 M Tris, pHϭ8.6, 400 l of 1.1 mg/ml p-hydroxycoumaric acid in DMSO, and 1.2 l 30% H 2 O 2 for 2 min at RT before exposure to ECL film (www.laborjournal.de/rubric/tricks/tricks/trick81.lasso).
FACS analysis
Immunofluorescence staining reactions and FACS analysis were performed as described [28] .
Online Supplemental material
The online version of this paper includes three Supplemental figures.
RESULTS
Association of surface Ii with MHC II
In B cells, Ii is present on the cell surface [28, 44] . It is not known, however, what fraction is associated with MHC II. As anti-Ii antibodies do not discriminate between free and MHC II-bound forms, we used sedimentation analysis to determine which fraction of surface Ii was bound to MHC II. To this end, the mouse B-lymphoma M12.C3.F6 was surface-labeled with membrane-impermeant NHSS-SS-biotin and lysed with 1% TX-100. As a control, the MHC II-negative B-lymphoma M12.C3 was lysed in the same way but without previous biotinylation.
With the use of sedimentation on velocity gradients, free Ii trimers were then separated from Ii-MHC II [45] . Immunoprecipitation of Ii from M12.C3.F6-derived gradient fractions revealed only very little biotinylated Ii (3Ϯ1%; Fig. 1A ) at the sedimentation position for free Ii ( Fig. 1B ; sedimentation coefficient ϳ3.6 S). By contrast, the vast majority of surface Ii (97Ϯ2%) sedimented in two peaks at lower positions corresponding to sedimentation coefficients of ϳ5.4 S and ϳ7.1 S. In these two populations, Ii was associated with a polypeptide of ϳ27 kDa, most likely the MHC II ␤-chain [28] . To demonstrate that surface Ii is indeed associated with MHC II ␣-and ␤-chains, Ii was immunoprecipitated from surface-biotinylated M12.C3F6 cells. The SDS-eluate from the immunomatrix was diluted and subjected to a second immunoprecipitation using polyclonal antibodies against the cytosolic tails of MHC II ␣-and ␤-chains. 
Coclustering of BCR and Ii-MHC II
As M12.C3.F6 cells express no detectable endogenous BCR (Supplemental Fig. 1A and B) , further work was carried out with NHHT-39, a stable BCR transfectant of M12.C3.F6, generously provided by Dr. Christopher Nelson and Dr. Emil Unanue (Washington University). This cell line displays moderate levels of membrane-anchored IgM at the cell surface (Supplemental Fig. 1B ) but does not differ from M12.C3.F6 in the expression of other markers (data not shown). To investigate whether BCR prefers the same membrane environment as Ii-MHC II, a coclustering assay was used. BCR and Ii-MHC II at the cell surface were individually labeled with primary and cross-adsorbed secondary antibodies on ice. A brief incubation at 37°C allowed the formation of patches that accumulate the membrane environment of their components. A shared preference for the same membrane environment should result in a statistical colocalization of the two components in the course of patch formation [40, 47, 48] . Control experiments with M12.C3.F6 and NHHT-39 cells ensured that secondary reagents did not cross-react with the directly labeled anti-BCR antibody (or vice versa) and that the binding of the anti-BCR antibody was specific for BCR (i.e., absent in not BCR-transfected M12.C3.F6 cells) at the photomultiplier settings of the CLSM (Supplemental Fig. 2A-C) . As demonstrated in Fig. 2A , clusters of BCR and Ii-MHC II partially colocalized in tangential and in equatorial confocal sections of NHHT-39 cells. The same result was obtained when a F(ab=) 2 anti-IgM (HCϩLC) was used instead of the anti IgG (HCϩLC) to label the BCR (compare Fig. 2A and Supplemental Fig. 2D ). To determine whether the observed coclustering was specific, BCR and other abundant surface proteins (TfnR and protein tyrosine phosphatase B220) were patched under similar conditions. Only very low colocalization between the sets of patches was detected, confirming the specificity of the assay (Fig. 2B and C) .
For a more quantitative assessment of coclustering, Rr values were calculated. We restricted our analysis to tangential sections of the plasma membrane, because of the higher resolution of the confocal microscope in the x-y direction (ϳ250 nm) compared with the z direction. As a positive control, M12.C3.F6 cells were incubated with species-different mAb against the ␣-and the ␤-subunit of MHC II (mAb H116-32 and P7/7, respectively) on ice, followed by cross-adsorbed secondary reagents and brief warming to allow for cluster formation. Quantitative analysis yielded a mean Rr of 0.90 Ϯ 0.05 (Fig.  2H, column 1) , which was, as expected for antibodies directed to the same molecule, close to the theoretical maximum of 1. As a negative control, MHC II and B220 were individually clustered on M12.C3.F6 cells. In this case, quantitative analysis revealed a mean Rr of 0.34 Ϯ 0.05 (Fig. 2H, column 2) . Although well above the expected value for noncorrelated samples (zero), this most likely reflects insufficient resolution of the CLSM relative to the size of the clusters and therefore, limits the sensitivity of our assay. Rr values for coclustering between BCR and TfnR were in the range of the negative control (0.32Ϯ0.07, Fig. 2H, column 4) . By contrast, Rr values for coclustering between BCR and Ii-MHC II (0.56Ϯ0.13; Fig. 2H,  column 3 ) distributed between positive and negative control, as expected for partial colocalization. This confirms our qualitative assessment and suggests that BCR and Ii-MHC II prefer a similar membrane environment.
Our results, so far, were obtained with a mouse B-lymphoma line, provoking the question of whether the observed coclustering also occurs in primary B-lymphocytes. To address this issue, we isolated splenocytes from C3H mice and expanded and activated B-lymphocytes by culturing in medium supplemented with 10 g/ml LPS for 48 h. As primary B-lymphocytes express high levels of FcRs, which may interfere with our analysis, we blocked the receptors with the rat mAb 2.4G2 before coclustering BCR and Ii-MHC II with noncross-reactive antibodies. As shown in Fig.  2D and quantified in Fig. 2H , column 8, BCR and Ii-MHC II on primary B-lymphocytes copatched to a similar extent as on the B-lymphoma cells. This suggests that the preference of BCR and Ii-MHC II for the same membrane environment is a general feature of B-lymphocytes.
To rule out that coclustering of BCR and Ii-MHC II was caused by pre-existing high-affinity interactions between the complexes (as opposed to a low-affinity sharing of the same membrane environment) or by asymmetric processes, recruiting a nonclustered component to a clustered one, we performed corecruitment assays. For this purpose, BCR or Ii-MHC II was clustered before chemical fixation and subsequent detection of the other component. As shown in Supplemental Fig. 3A and B, neither the clustering of Ii-MHC II (Supplemental Fig. 3A) nor that of BCR (Supplemental Fig. 3B ) led to a redistribution of BCR (Supplemental Fig. 3A) or Ii-MHC II (Supplemental Fig. 3B ), respectively, to the clustered protein. We noted that Ii-MHC II displayed a patched surface distribution, even in the absence of experimental clustering (Supplemental Fig. 3B ). This possibly reflects gathering at internalization sites, as Ii-MHC II is cleared rapidly from the plasma membrane [28, 49] . Apparently, however, this type of clustering was not sufficient to induce colocalization with patched BCR. In summary, our findings rule out that copatching of BCR and Ii-MHC II was caused by a pre-existing, high-affinity interaction between the complexes or asymmetric recruitment processes.
Whereas clustering of BCR by polyvalent or membrane-bound monovalent antigen is well-documented [6, 8, 50] , it remains to be established whether physiological ligands of Ii are capable of clustering it. To this end, NHHT-39 cells were treated with the currently only known ligand of Ii, MIF [51] , followed by independent clustering of cell-bound MIF and BCR. As shown in Fig. 2E and H, column 5, cell-bound MIF and BCR partially coclustered (Rrϭ0.56Ϯ0. 17) , similar to what we observed with BCR and Ii-MHC II ( Fig. 2A and H, column 3) . By contrast, binding of MIF without further clustering did not lead to its colocalization with patched BCR (Supplemental Fig. 3C ). This suggests that homotrimeric MIF cannot cluster Ii-MHC II sufficiently enough to induce its colocalization with patched BCR. To ensure that MIF was specifically bound to Ii on NHHT-39 cells, we examined whether cell-bound MIF coclustered with Ii-MHC II. We observed a quantitative overlap between both clustered molecules, suggesting that Ii-MHC II was the prevalent binding site for MIF on NHHT-39 cells (data not shown). We conclude that MIF can induce colocalization of Ii-MHC II with clustered BCR when it is properly oligomerized.
Our results suggest that clustering of BCR and Ii-MHC II occurs via a common membrane domain. As BCR and Ii-MHC II have been described to associate with raft-like membrane domains [13-17, 31, 32, 52], we investigated whether BCR coclusters with other membrane raft markers, such as peptide-loaded MHC II [53] or the G M 1 [47] . BCR coclustered with peptideloaded, Ii-free MHC II to a large extent (Fig. 2F and H, column 6; Rrϭ0.65Ϯ0.15), whereas G M 1, patched by a CTB, displayed no significant colocalization with BCR clusters (Rrϭ0.29Ϯ0.1; Fig.   2G and H, column 7). This suggests that the membrane environment preferred by the BCR is not a typical membrane raft characterized by a high level of sphingolipids.
Coendocytosis and actin-independent clustering of BCR and Ii-MHC II
We next addressed the question of whether BCR and Ii-MHC II or peptide-loaded, mature MHC II were internalized together upon coclustering. As shown in Fig. 3A and B, we often observed cointernalization of BCR and Ii-MHC II (A) or of BCR and peptide-loaded MHC II (B) after 10 -15 min incubation at 37°C. Thus, the proteins are endocytosed together once they have been induced to coalesce into a common membrane environment at the plasma membrane. We also noticed that the coclusters were internalized only gradually (data not shown), consistent with the idea that surface-located BCR clusters serve signaling functions that interfere with efficient endocytosis [7] .
The endocytosis of clustered BCR has been shown to depend partially on dynamic cortical actin [19, 54] , whereas Ii-MHC II has been implicated in interacting with myosin II and actin upon BCR clustering and endocytosis [27] . Furthermore, dynamic cortical F-actin has been linked to the stabilization of raft-like microclusters of GPI-linked proteins and proposed to fulfill a fundamental role in membrane raft organization [55] . Therefore, dynamic F-actin in cortical cell regions might support the coalescence of clusters of BCR and Ii-MHC II. To address this point, NHHT-39 cells were treated with 1 M Lat B during a coclustering experiment. Under these conditions, virtually all F-actin was eliminated from cortical cell regions except few weak punctae, as evidenced by phalloidin staining (Fig. 3D ). Despite these dramatic changes, coclusters of BCR and Ii-MHC II were readily detected in tangential and equatorial confocal sections (Fig. 3C) . Thus, assembly or presence of cortical F-actin does not appear to be required for the antibody-induced cotargeting of the BCR and Ii-MHC II to a common membrane environment.
Cotargeting of BCR and Ii-MHC II to a DRM
To explore the membrane environment of BCR and Ii-MHC II in more detail, detergent extraction experiments, with or without previous clustering of BCR or Ii-MHC II, were performed. First, a standard TX-100 extraction procedure [13] was tested. After antibody-mediated BCR clustering, NHHT-39 cells were extracted with 1% TX-100 on ice and subsequently fractionated by flotation on a 5-35% sucrose step gradient devoid of detergent. As shown in Fig. 4 , this procedure yielded only very little mature BCR in DRMs (see overexposed blot). Most of the mature BCR was detected in the pellet, suggesting that BCR clusters were stripped off their membranes by TX-100 and formed dense immunoprecipitates. Immature, ER-localized BCR, which migrated at a lower apparent molecular weight, was not affected by the clustering reaction and remained soluble at the bottom of the gradient. Without clustering, neither flotation nor pelleting of mature BCR was observed. As a result of the very low degree of association of clustered BCR with TX-100-resistant membranes, we switched to a milder, Brij 98-based extraction procedure developed for the isolation of Ii-MHC II-containing DRMs [31, 52] . Even under these conditions, no significant flotation of clustered, mature BCR was detected ( Fig. 4 ; Brij 98, long, 37°C). As with the TX-100-based procedure, the bulk of clustered, mature BCR was present as an immunoprecipitate in the pellet after ultracentrifugation.
We then resorted to a very mild, rapid Brij 98 extraction protocol [42] . In a slightly modified procedure, PNMs of NHHT-39 cells were extracted briefly with 0.5% Brij 98 at 37°C and then subjected to flotation on 10 -40% linear sucrose gradients devoid of detergent. Under these conditions, all mature, clustered BCR floated into the gradient. No mature BCR molecules were detected in the bottom fractions of the gradient or the pellet (Fig. 4; Brij 98, short, 37°C ). We noted that even without clustering, some mature BCR distributed to fractions 4 and 5 of the gradient (peak in fraction 4), whereas clustered BCR floated to a lower position (fractions 4 -7, peak in fraction 6). The flotation of mature BCR was not caused by insufficient extraction of nonraft membranes, as membrane proteins not associated with rafts, such as lamp-1 or immature BCR, were quantitatively solubilized and stayed in the bottom fractions. Immature Ii and B220 did not completely distribute to bottom fractions but partially floated into the gradient. Whereas we cannot rule out nonspecific flotation, the result may indicate a weak tendency of these proteins to associate with Brij 98 DRMs. In fact, B220 has been re- ported to be recruited to G M 1-containing rafts after BCR stimulation [56] . Some tightly membrane raft-associated proteins appear to distribute to DRM-like structures in the ER [57, 58] . Ii-MHC II may belong to this group as a result of its very high association with DRMs [31] . Membrane raft components, such as MHC II, G M 1, and mature Ii, almost quantitatively floated to fractions 3-7. They peaked at slightly higher positions (fractions 4 and 5) than clustered BCR (fraction 6). Interestingly, upon clustering at the cell surface, mature Ii appeared to shift partially toward lower-gradient fractions-now cofloating with clustered BCR (Fig. 4 ; lower anti-Ii blot). Our results are consistent with a low, inherent tendency of the BCR to distribute to DRMs, which is enhanced by clustering and results in coflotation with mature Ii-MHC II.
To investigate whether clustered BCR and Ii were present on the same DRM, we used P4H5-adsorbed polyclonal antiIgM F(ab=) 2 to cluster BCR on NHHT-39 cells. Ii-containing DRMs (short Brij 98 protocol) were immunoisolated using mAb P4H5 and PGS. When this procedure was performed in the absence of detergent, a strong band of coisolated IgM molecules could be detected by Western blot (Fig. 5) . This band disappeared completely as soon as 0.1% Brij 98 was included in the washing steps, suggesting that the interaction between clustered BCR and Ii was only indirect, via membranes that were susceptible to prolonged detergent exposure. Nevertheless, the procedure appeared to be specific, as no signal for Ii or BCR was obtained when S4B beads were used for retrieval. Furthermore, no B220, which was present in DRM fractions, was coisolated with DRMs containing Ii-MHC II, regardless of the presence or absence of detergent. This suggests that (1) Ii-MHC II was present on a different subpopulation of DRMs compared with B220 and that (2) DRMs were not retrieved nonspecifically. Taken together, our results support the 2 , adsorbed against mAb P4H5. Subsequently, DRMs were produced according to the short Brij 98 extraction protocol. Ii-containing DRMs were immunoisolated with mAb P4H5 and PGS (Prot.G). Preclear S4B beads served as control. The matrices were washed with buffer containing 0.1% Brij 98 or not, eluted with SDS sample buffer, and blotted for B220 (top), BCR (middle), and Ii (bottom). Total DRM: 1/20 vol Ii-containing DRMs (input control for B220). The original blots, from which this figure has been assembled, are shown in Supplemental Fig. 1C . Note that Ii-positive DRMs contained BCR but no B220. The sensitivity to prolonged detergent exposure (washes) suggests that BCR and Ii-MHC II interact only indirectly via lipids. immat., immature.
notion that clustered BCR and Ii-MHC II were present in the same DRM that exhibited an unusual high susceptibility to detergents.
Enhanced signal transduction by coclusters of BCR and Ii-MHC II
A hallmark of BCR engagement with polyvalent antigen is tyrosine phosphorylation and the subsequent recruitment of a multicomponent signalosome to the activated BCR [4, 5] . To test whether the coclustering of BCR and Ii-MHC II affects BCR-triggered signal transduction, NHHT-39 cells were pretreated on ice with antibodies against the BCR alone or against the BCR and Ii. NHHT-39 cells not treated with antibodies served as controls. Clustering was induced by incubation at 37°C for various times, followed by lysis and Western blotting with the phosphotyrosine-specific mAb 4G10. A blot against the TfnR served as a loading control (Fig. 6A , lower row of blots). We detected tyrosine phoshorylation of two proteins at apparent molecular weights of ϳ60 kDa and ϳ120 kDa, which increased up to 5 min after BCR clustering and at later times, reverted to background levels (Fig. 6A , arrowheads, compare left and middle blots). The intensity and persistence of these bands were enhanced further in samples that had been subjected to independent clustering of BCR and Ii-MHC II (Fig. 6A, right blot) . To obtain quantitative data, we focused our analysis on a narrower time window and analyzed the tyrosine phoshorylation of the ϳ60-kDa band, which consistently gave a higher signal to background ratio than the ϳ120-kDa band. All values were standardized to the protein Akt as a loading control. In agreement with the data in Fig.  6A , tyrosine phosphorylation of the ϳ60-kDa band increased approximately twofold within 2 min of clustering of BCR and then reverted to background values within 15 min (Fig. 6B) . By contrast, coclustering of BCR and Ii-MHC II resulted in a fourfold elevation of the signal for the phosphorylated ϳ60-kDa polypeptide within 2 min of coclustering. The clustering of Ii-MHC II alone did not cause tyrosine phosphorylation above the levels of controls (data not shown).
We also tried to assess changes in the phosphorylation of other proteins that have been described to be activated after BCR clustering [4, 5] . To this end, similar clustering experiments, as described above, were performed and analyzed by Western blotting for phosphorylated forms of Lyn, Erk, or Akt. Whereas Lyn expression was found to be too low for quantification in NHHT-39, Erk and Akt showed high activation, even in the absence of BCR clustering. Attempts to reduce the background phosphorylation by standard serum depletion protocols strongly reduced the viability of NHHT cells. We also noticed a sharp drop in surface expression of Ii-MHC II upon serum reduction, probably as this complex is only a transient intermediate in the MHC II pathway and as such, critically dependent on optimal biosynthetic conditions [28] . Without serum depletion, phosphorylation of Erk revealed only a moderate enhancement over background (approximately twofold), 2-5 min after induction of BCR clustering (data not shown). The coclustering of BCR and Ii did not result in a further in- crease of Erk phosphorylation (data not shown). The clustering of BCR transiently enhanced Akt phosphorylation over background values at 5 min (Fig. 6C) . This effect was increased further after coclustering of BCR and Ii-MHC II. Overall, however, these changes were only small (ϳϩ15% and ϩ30%, respectively) and hardly exceeded the sd of the means of three experiments (Fig. 6C) . This is contrasted by the more pronounced enhancement of tyrosine phosphorylation of the ϳ60-kDa polypeptide upon coclustering of BCR and Ii-MHC II (Fig. 6B) . Taken together, our results suggest that coclustering of BCR and Ii-MHC II augments BCR-driven tyrosine phosphorylation and selected signaling pathways originating at the BCR.
DISCUSSION
In this work, we show that BCR and Ii-MHC II could be induced to coalesce at the plasma membrane of mouse B cells. Based on two surrogate criteria, we present evidence that an unusual membrane raft mediates cohesion between clustered BCR and Ii-MHC II. (1) Clustered BCR at the cell surface was partially colocalized with known raft-associated plasma membrane components, such as Ii-MHC II and peptide-loaded MHC II, but not with G M 1 when these molecules were also patched. This coclustering phenotype did not require F-actin. (2) Clustered BCR and Ii were immunoisolated in the same DRM prepared by a very mild, Brij 98-based extraction procedure. Both assays do not report on the state of the molecules in an unperturbed cell but visualize an inherent tendency of molecules to associate with induced, raft-like structures [34, 59] .
Numerous studies have reported a tendency of mature BCRs to associate with DRMs [13] [14] [15] [16] [17] . However, unlike genuine membrane raft components, which often show a robust coflotation with DRMs, the association of the BCR with DRMs requires previous clustering by antibodies or by a polyvalent antigen, a procedure known to promote the formation of stable, raft-like structures on live cells [47] and to enhance the association with DRMs [40, 47] . Even under these conditions, the BCR was generally found to be only weakly associated with DRMs [13] [14] [15] , consistent with our results using standard extraction protocols. Only a short, Brij 98-based procedure allowed the efficient isolation of clustered, mature BCRs in DRMs [42] . We also observed some flotation of mature BCRs in the absence of previous clustering under these conditions, reminiscent of what was found for the TCR [42] . Nonclustered BCR floated at a distinct, lower density on the sucrose gradients, suggesting that clustering changed the chemical composition of the DRMs generated upon detergent extraction. Similar density shifts upon antibody-induced clustering have been described for MHC I and MHC II [40] and may be linked to altered endocytic pathway selection (unpublished results).
To our knowledge, no interactions between BCR and Ii-MHC II or peptide-loaded MHC II at the plasma membrane have been reported to date. Various studies have addressed the BCR-driven rerouting of Ii-MHC II and the reorganization of endocytic compartments upon polyvalent BCR engagement [8, [25] [26] [27] 60] . These processes were found to promote the "late" convergence of antigen-loaded BCR and Ii-MHC II in a degradative organelle, as opposed to the "early" convergence of both molecules at the plasma membrane. The potential of BCR and Ii-MHC II to combine within a membrane raft might, however, also affect their fate in late endocytic compartments by holding the two complexes in close proximity. This might bring about the concomitant degradation of Ii and antigen and lead to the coordinate "hand over" of suitable antigen epitopes to nascent MHC II, similar to what has been described for a cell-surface model system [61] . Conceivably, such proximity effects might affect the selection of antigenic peptides and their dominance or crypticity in the immune response [62] . It is interesting that the degradation products of Ii down to MHC II-bound p12 showed a high degree of DRM association [31, 32] . Even MHC II molecules loaded with the groove-binding Ii peptide still showed substantial, albeit lower, DRM association [31] . Thus, all precursors of loading-competent MHC II exhibit a preference for membrane environments similar to the one in which clustered BCR is concentrated. Despite of this, Ii has not yet been detected in proteomic analyses of DRMs from B-lymphocytes [16, 17, 63] . This failure to detect Ii in (BCR-containing) DRMs is very likely to be a result of the use of TX-100 in these studies: as we have previously shown, Ii-MHC II was solubilized almost completely by TX-100 [52] , as opposed to its robust DRM association in Brij 98 or Brij 58 [31, 32] . In our view, this differential detergent resistance explains why Ii-MHC II was missed in TX-100-based proteomic analyses of B cell DRMs.
There appears to be an inconsistency between the results of our coclustering experiments and our DRM analyses: we did not observe corecruitment of Ii to the BCR on live cells when only the BCR was clustered (Supplemental Fig. 3B ). In the immunoisolation experiment, however, clustering of BCR was sufficient for the colocalization with Ii in the same DRM (Fig.  5 ). This could have been caused by the strong affinity of Ii-MHC II for a subtype of Brij 98-resistant membranes, even in the absence of antibody-induced clustering [31, 52] . Alternatively, Brij 98 might have induced some condensation of Ii-MHC II during extraction, and this could have bypassed the need for antibody-mediated clustering. Detergent-induced membrane condensation has been reported for TX-100 [64, 65] and may also occur with detergents, such as Brij 98 or Brij 96, although these are less likely than TX-100 to perturb the architecture of membrane regions resistant to extraction [59] .
Activation of BCR by polyvalent antigen has been reported to trigger a local reorganization of cortical actin [66] . Specifically, BCR activation leads to dephosphorylation of ezrin and related proteins, causing them to dissociate from actin and from membrane rafts [17, 67] . These changes, however, are only transient, leaving an ϳ10-min window for membrane rearrangements in the vicinity of the activated BCR, consistent with data on BCR-induced tyrosine phosphorylation [7, 54] (see also Fig. 6A and B) . The coclustering of BCR and Ii-MHC II was readily detected within 5 min of warming to 37°C ( Fig.  2A and Supplemental Fig. 2A) , well within the window of reduced cortical actin involvement of the clustered BCR [17, 66, 67] . Thus, a role for (F-) actin in coclustering appears to be unlikely. In agreement with this, Lat B treatment of NHHT-39 cells virtually eliminated cortical F-actin in NHHT-39 cells but did not interfere with coclustering of BCR and Ii-MHC II (Fig.  3C and D) . This suggests that colocalization was driven by F-actin-independent coalescence of membrane rafts in experimentally induced clustering. This conclusion is also supported by the observation that prolonged exposure to Brij 98 was sufficient to separate BCR from immunoisolated Ii, implicating lipid-rather than protein-based interactions in the structural maintenance of the DRMs (Fig. 5) . Recent studies, however, suggest an active role of cortical actin in transiently stabilizing raft-like nano-and microclusters in the plasma membrane [55, 68, 69] . Possibly the strong oligomerization of the BCR by antibodies or by polyvalent antigen may provide sufficient stabilization of membrane rafts to circumvent a potential requirement for cortical F-actin.
The first part of our study revealed a stringent dependence on clustering to induce colocalization of Ii-MHC II and BCR. This requirement also pertained to a physiological ligand of Ii-MIF ( Fig. 2E and Supplemental Fig. 3C ). However, the need for an oligomerized antigen to induce BCR clustering and B cell activation appears to be dispensable, if monomeric antigen is tethered to cellular membranes [6, 50] . Membranebound antigens are of relevance in vivo, as monocytic [70] , dendritic [71] , as well as follicular-dendritic [72] cells have been shown to be involved in antigen delivery to B-lymphocytes. Recent evidence suggests that MIF can also be displayed in a cell-bound form to other cells that expressed Ii or other MIF receptors, such as CXCR2 and CXCR4 [73] . Although it remains to be established in which oligomerization state MIF was present on the displaying cells, the fact that cell-bound MIF served as a functional ligand in trans opens the possibility that it might also induce clustering of Ii.
The abundance of Ii-MHC II over free Ii on the cell surface ( Fig. 1) , the identical coclustering with the BCR of MIF and mAb P4H5 ( Fig. 2A, E, and H) , and the complete coclustering of MIF and mAb P4H5 on the cell surface (data not shown) suggest that Ii-MHC II can serve as a receptor for MIF. Although this is consistent with biochemical data revealing the trimerization region C-terminal to the MHC II-binding site of Ii as a key site for interacting with MIF [74] , recent evidence suggests that MHC II binding to Ii might interfere with the MIF-Ii interaction [75] . This apparent contradiction to our biochemical data may be explained by the presence of partially MHC II-saturated Ii trimers at the surface of NHHT cells. Such structures would allow free MIF-binding sites and MHC II molecules to be present in the same complex. The fact that we observed two different subpopulations of Ii-MHC II complexes at the surface of NHHT-39 cells that displayed lower S-values (ϳ5.4 S and ϳ7.1 S) than previously reported for nonameric complexes of Ii and MHC II molecules (11.1 S) [45] would support such a view, although the precise molecular composition of these complexes remains to be established.
Antigen and MIF bound to the surface of ADCs might therefore induce the coalescence of BCR and Ii-MHC II on the B cell, which in turn, triggers corouting into endocytic compartments, similar to what we observed upon antibodymediated clustering (Fig. 3A and B) . The recruitment of secretory B cell lysosomes to immunological synapses could offer an explanation of how antigen and MIF are retrieved from the ADC, thus allowing endocytosis to proceed [76] . Our hypothesis is summarized in Fig. 7 . The proposed, novel function of MIF as a "targeting factor" for nascent MHC II in B cells should be expected to influence MHC II loading, antigen presentation, and ultimatively, T-dependent B cell responses. This prediction is in agreement with the observation of impaired Th2 responses in MIF knockout mice [77, 78] and should provide a basis for future investigation. AUTHORSHIP J.T.H. and R.L. designed the research, performed experiments, analyzed the data, and wrote the manuscript.
